Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-12

Clinical Trial Update: Risk Factors for Linezolid Resistance in Staphylococcus Aureus

View source ↗

Summary

Clinical trial update examining risk factors for linezolid resistance in Staphylococcus aureus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)

Snippet

Sponsor: University of Pittsburgh | Conditions: Linezolid Resistance, Staphylococcus Aureus | Status: COMPLETED